Axsome Therapeutics (AXSM) Short Interest Ratio & Short Volume → Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI (From Banyan Hill Publishing) (Ad) Free AXSM Stock Alerts $73.69 +1.98 (+2.76%) (As of 04/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Axsome Therapeutics Short Interest DataCurrent Short Volume7,750,000 sharesPrevious Short Volume7,650,000 sharesChange Vs. Previous Month+1.31%Dollar Volume Sold Short$528.63 millionShort Interest Ratio / Days to Cover10.7Last Record DateApril 15, 2024Outstanding Shares47,374,000 sharesPercentage of Shares Shorted16.36%Today's Trading Volume505,671 sharesAverage Trading Volume715,375 sharesToday's Volume Vs. Average71% Short Selling Axsome Therapeutics ? Sign up to receive the latest short interest report for Axsome Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAXSM Short Interest Over TimeAXSM Days to Cover Over TimeAXSM Percentage of Float Shorted Over Time Ad InvestorPlaceHas Jeff Bezos Found the Next Nvidia?If you’ve sat back and watched companies like Nvidia and AMD soar over 2,000% over the past several years… And wondered what was next… This is a fast-moving story, but if you want the chance to profit alongside Jeff Bezos in the next big tech trend, go ahead and…Click Here for Full Details Axsome Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20247,750,000 shares $528.63 million +1.3%N/A10.7 $68.21 3/31/20247,650,000 shares $610.47 million +4.8%N/A10.4 $79.80 3/15/20247,300,000 shares $551.44 million -2.3%N/A9.4 $75.54 2/29/20247,470,000 shares $607.91 million -0.7%N/A10.2 $81.38 2/15/20247,520,000 shares $702.82 million +0.4%N/A10.9 $93.46 1/31/20247,490,000 shares $674.32 million -10.0%N/A11.5 $90.03 Get the Latest News and Ratings for AXSM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Axsome Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20248,320,000 shares $708.95 million -1.2%N/A11.9 $85.21 12/31/20238,420,000 shares $670.15 million +0.7%N/A12.4 $79.59 12/15/20238,360,000 shares $610.20 million -1.1%N/A12.6 $72.99 11/30/20238,450,000 shares $569.95 million +10.6%N/A12.3 $67.45 11/15/20237,640,000 shares $460.00 million +4.0%N/A11.5 $60.21 10/31/20237,350,000 shares $457.76 million -3.2%N/A11 $62.28 10/15/20237,590,000 shares $504.51 million +1.6%N/A10.9 $66.47 9/30/20237,470,000 shares $522.08 million -8.0%N/A10.4 $69.89 9/15/20238,120,000 shares $611.11 million -1.5%N/A9.6 $75.26 8/31/20238,240,000 shares $665.79 million -3.5%N/A9.3 $80.80 8/15/20238,540,000 shares $609.41 million -5.7%N/A9.4 $71.36 7/31/20239,060,000 shares $710.94 million -2.6%N/A9.6 $78.47 7/15/20239,300,000 shares $684.76 million +1.8%N/A10.5 $73.63 6/30/20239,140,000 shares $656.80 million +17.8%24.5%10.1 $71.86 6/15/20237,760,000 shares $656.73 million +0.3%22.2%9.9 $84.63 5/31/20237,740,000 shares $571.06 million +0.9%22.2%9.9 $73.78 5/15/20237,670,000 shares $596.50 million -4.0%22.0%9.1 $77.77 4/30/20237,990,000 shares $571.52 million +1.9%23.3%8.9 $71.53 4/15/20237,840,000 shares $537.04 million -4.5%22.8%8.6 $68.50 3/31/20238,210,000 shares $506.39 million -3.8%23.9%8.7 $61.68 3/15/20238,530,000 shares $528.26 million +1.6%24.8%8.9 $61.93 2/28/20238,400,000 shares $572.80 million +4.4%24.5%8.5 $68.19 2/15/20238,050,000 shares $508.28 million +5.4%23.5%6.9 $63.14 1/31/20237,640,000 shares $573 million -3.8%21.6%6.2 $75.00 1/15/20237,940,000 shares $534.36 million +5.2%22.4%5.9 $67.30 12/30/20227,550,000 shares $582.33 million +2.4%21.3%5.4 $77.13 12/15/20227,370,000 shares $570.88 million -7.1%20.8%5.1 $77.46 11/30/20227,930,000 shares $573.26 million +16.8%22.8%5.3 $72.29 11/15/20226,790,000 shares $372.91 million +9.0%19.5%5.2 $54.92 10/31/20226,230,000 shares $281.28 million +8.5%19.3%3.6 $45.15 10/15/20225,740,000 shares $275.52 million +2.5%17.8%3.7 $48.00 9/30/20225,600,000 shares $249.87 million -1.8%17.4%3.8 $44.62 9/15/20225,700,000 shares $351.63 million -3.7%17.7%2.9 $61.69 8/31/20225,920,000 shares $377.70 million +8.4%18.5%3.1 $63.80Has Jeff Bezos Found the Next Nvidia? (Ad)If you’ve sat back and watched companies like Nvidia and AMD soar over 2,000% over the past several years… And wondered what was next… This is a fast-moving story, but if you want the chance to profit alongside Jeff Bezos in the next big tech trend, go ahead and…Click Here for Full Details AXSM Short Interest - Frequently Asked Questions What is Axsome Therapeutics' current short interest? Short interest is the volume of Axsome Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 7,750,000 shares of AXSM short. Learn More on Axsome Therapeutics' current short interest. What is a good short interest ratio for Axsome Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXSM shares currently have a short interest ratio of 11.0. Learn More on Axsome Therapeutics's short interest ratio. Which institutional investors are shorting Axsome Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Axsome Therapeutics: Simplex Trading LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Axsome Therapeutics' short interest increasing or decreasing? Axsome Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 7,750,000 shares, an increase of 1.3% from the previous total of 7,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Axsome Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Axsome Therapeutics: Prestige Consumer Healthcare Inc. (3.72%), Insmed Incorporated (6.33%), Biohaven Ltd. (10.10%), Ultragenyx Pharmaceutical Inc. (5.32%), CymaBay Therapeutics, Inc. (5.10%), HUTCHMED (China) Limited (0.30%), Amicus Therapeutics, Inc. (10.57%), Bausch Health Companies Inc. (5.81%), Xenon Pharmaceuticals Inc. (3.47%), Crinetics Pharmaceuticals, Inc. (7.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Axsome Therapeutics stock? Short selling AXSM is an investing strategy that aims to generate trading profit from Axsome Therapeutics as its price is falling. AXSM shares are trading up $1.98 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Axsome Therapeutics? A short squeeze for Axsome Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AXSM, which in turn drives the price of the stock up even further. How often is Axsome Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXSM, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Prestige Consumer Healthcare Short Interest Insmed Short Interest Biohaven Short Interest Ultragenyx Pharmaceutical Short Interest CymaBay Therapeutics Short Interest HUTCHMED Short Interest Amicus Therapeutics Short Interest Bausch Health Companies Short Interest Xenon Pharmaceuticals Short Interest Crinetics Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AXSM) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press